Nurse Navigators and Timely Genomic Testing in Breast Cancer
Nurse Navigators and Timely Genomic Testing in Breast Cancer
The aim of this project was to develop a timely, evidence-based process for the use of Oncotype DX test results to enhance decision making for women with early-stage, ER+, HER2/neu-negative breast cancer. The measures of success of this project were to (a) improve the turnaround time for ordering Oncotype DX, (b) improve the turnaround time for reporting results, and (c) comply with the NCCN recommendations to test eligible patients.
Ordering turnaround time was defined as the average number of days from surgery to the date the test is ordered. Reporting turnaround time was defined as the average number of days from surgery to the date the test result was reported.
Aim of the Project
The aim of this project was to develop a timely, evidence-based process for the use of Oncotype DX test results to enhance decision making for women with early-stage, ER+, HER2/neu-negative breast cancer. The measures of success of this project were to (a) improve the turnaround time for ordering Oncotype DX, (b) improve the turnaround time for reporting results, and (c) comply with the NCCN recommendations to test eligible patients.
Ordering turnaround time was defined as the average number of days from surgery to the date the test is ordered. Reporting turnaround time was defined as the average number of days from surgery to the date the test result was reported.
Source...